Literature DB >> 10889128

Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

I Lemieux1, A Pascot, C Couillard, B Lamarche, A Tchernof, N Alméras, J Bergeron, D Gaudet, G Tremblay, D Prud'homme, A Nadeau, J P Després.   

Abstract

BACKGROUND: The present study tested the hypothesis that simple variables, such as waist circumference and fasting plasma triglyceride (TG) concentrations, could be used as screening tools for the identification of men characterized by a metabolic triad of nontraditional risk factors (elevated insulin and apolipoprotein [apo] B and small, dense LDL particles). METHODS AND
RESULTS: Results of the metabolic study (study 1) conducted on 185 healthy men indicate that a large proportion (>80%) of men with waist circumference values >/=90 cm and with elevated TG levels (>/=2.0 mmol/L) were characterized by the atherogenic metabolic triad. Validation of the model in an angiographic study (study 2) on a sample of 287 men with and without coronary artery disease (CAD) revealed that only men with both elevated waist and TG levels were at increased risk of CAD (odds ratio of 3.6, P<0.03) compared with men with low waist and TG levels.
CONCLUSIONS: It is suggested that the simultaneous measurement and interpretation of waist circumference and fasting TG could be used as inexpensive screening tools to identify men characterized by the atherogenic metabolic triad (hyperinsulinemia, elevated apo B, small, dense LDL) and at high risk for CAD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10889128     DOI: 10.1161/01.cir.102.2.179

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  191 in total

1.  Obesity: the dire consequences of a genetic program for survival?

Authors:  A M Sharma; J P Després
Journal:  J Mol Med (Berl)       Date:  2001       Impact factor: 4.599

2.  Abdominal obesity and the "hypertriglyceridaemic waist" phenotype.

Authors:  P Little; C D Byrne
Journal:  BMJ       Date:  2001-03-24

3.  Evaluation and management of atherogenic dyslipidemia: beyond low-density lipoprotein cholesterol.

Authors:  J P Després; I Lemieux; G R Dagenais; B Cantin; B Lamarche
Journal:  CMAJ       Date:  2001-11-13       Impact factor: 8.262

4.  Waist circumference and cardiovascular risk.

Authors:  John Hickey
Journal:  Can Fam Physician       Date:  2003-10       Impact factor: 3.275

5.  The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk prospective population study.

Authors:  Benoit J Arsenault; Isabelle Lemieux; Jean-Pierre Després; Nicholas J Wareham; John J P Kastelein; Kay-Tee Khaw; S Matthijs Boekholdt
Journal:  CMAJ       Date:  2010-07-19       Impact factor: 8.262

6.  Visceral adiposity index, hypertriglyceridemic waist and risk of diabetes: the China Health and Nutrition Survey 2009.

Authors:  T Du; X Sun; R Huo; X Yu
Journal:  Int J Obes (Lond)       Date:  2013-09-19       Impact factor: 5.095

7.  The association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene with the metabolic characteristics in Chinese women with polycystic ovary syndrome.

Authors:  Jiejin Yang; Hao Gong; Wei Liu; Tao Tao
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

8.  Comparison of body composition changes between atazanavir/ritonavir and lopinavir/ritonavir each in combination with tenofovir/emtricitabine in antiretroviral-naïve patients with HIV-1 infection.

Authors:  Graeme J Moyle; Hélène Hardy; Awny Farajallah; Michelle DeGrosky; Donnie McGrath
Journal:  Clin Drug Investig       Date:  2014-04       Impact factor: 2.859

Review 9.  The role of triglycerides in cardiovascular risk.

Authors:  Puneet Gandotra; Michael Miller
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

10.  Visceral adiposity and risk of coronary heart disease in relatively lean Chinese adults.

Authors:  Xianglan Zhang; Xiao-Ou Shu; Honglan Li; Gong Yang; Yong-Bing Xiang; Qiuyin Cai; Bu-Tian Ji; Yu-Tang Gao; Wei Zheng
Journal:  Int J Cardiol       Date:  2013-03-01       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.